Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Biochem Pharmacol. 2012 Jul 22;84(7):936–948. doi: 10.1016/j.bcp.2012.07.010

Table 1.

Affinities of hGRPR point mutants in Group I for [D-Tyr6, β-Ala11, Phe13, Nle14]Bn(6-14) [Univ.Lig]

No. LOCATION POINT MUTATION Univ.Lig Affinity (nM ± SEM)
Wild type hGRPR 0.1×106 - 0.100 ± 0.006
1 UTM2 L90A 0.053 ± 0.003
2 T92A 0.53 ± 0.03*
3 V96A 0.13 ± 0.42
4 EC2 D97N 1.24 ± 0.01*
5 A98L 0.031 ± 0.007
6 S99I 0.010 ± 0.013
7 R100A 0.094 ± 0.004
8 Y101N 0.038 ± 0.001
9 Y101A 0.120 ± 0.01
10 D104K 0.20 ± 0.01*
11 R110S 0.074 ± 0.009
12 R110A 0.087 ± 0.003
13 R110D 0.026 ± 0.001
14 G112V 2.98 ± 0.15*
15 UTM3 L115A 0.050 ± 0.031
16 I116A 0.18 ± 0.01*
17 I119A 0.11 ± 0.01
18 L121A 0.48 ± 0.02*
19 UTM4 A172T 0.078 ± 0.009
20 I173T 0.066 ± 0.008
21 E175Q 0.15 ± 0.01*
22 A176G 0.12 ± 0.01
23 EC3 F193A 0.078 ± 0.011
24 Y199L 0.069 ± 0.003
25 P200L 0.064 ± 0.004
26 S202N 0.056 ± 0.003
27 L205A 0.096 ± 0.004
28 M212F 0.10 ± 0.01
29 UTM5 F215A 0.063 ± 0.005
30 F218A 0.074 ± 0.001
31 UTM6 N280A 0.037 ± 0.003
32 H281A 0.22 ± 0.01*
33 I283A 0.47 ± 0.02*
34 Y284A 5.78 ± 0.33*
35 EC4 R287N 7.07 ± 0.47*
36 Y289A 0.063 ± 0.008
37 M298P 0.22 ± 0.01*
38 H300S 0.99 ± 0.03*
39 S304A 0.10 ± 0.01
40 UTM7 I305A 0.14 ± 0.01
41 R308A 0.28 ± 0.02*

Group I (n=41) comprise point mutants made in a hGRPR amino acids which are present in all BnR’s with high affinity for [D-Tyr6, β-Ala11, Phe13, Nle14]Bn(6-14) [Univ.Lig] but which different from that in a similar position in hCCKAR identified as described in Methods. The affinities (IC50) were measured in whole cell radioligand binding assays using 50 pM 125I- [D-Tyr6, β-Ala11, Phe13, Nle14]Bn(6-14) [Univ.Lig] as described in Methods and Fig. 3 legend. Each point mutation’s affinity for Univ.Lig was compared to that of cells expressing wild type GRPR which bound comparable amounts of radiolabeled ligand. Data are partially from the dose-inhibition curves of representative mutants shown in Fig. 3. IC50’s, the concentration causing half-maximal inhibition, were calculated from the dose-inhibition curves of [D-Tyr6, β-Ala11, Phe13, Nle14]Bn(6-14) [Univ.Lig] as described in Methods. Values are means ± SEM from three experiments for those mutants showing no affinity change and 4 to 6 experiments for any showing differences from control and in each experiment each point was measured in duplicate.

*

(in bold)=p<0.05 compared to wild type hGRPR expressed at similar expression levels.